A Phase 1/2 Study of Anti-CD19 CAR-T Cell Therapy in ANCA Vasculitis
Not Yet Recruiting Phase 1,Phase 2 NCT06590545
Study Description
A Study of a New Treatment for ANCA-Associated Vasculitis Using Modified Immune Cells
Study Details
- Registry ID:
- NCT06590545
- Conditions:
- ANCA-IgG-positive ANCA Associated Vasculitis
- Phase:
- Phase 1,Phase 2
- Target Enrollment:
- 8 participants
- Start Date:
- Age Range:
- 18–75 years
- Healthy Volunteers:
- No
Interested in Participating?
Check your eligibility and learn more about this study on TrialScreen.